TYPE Stocks
GROUP Stocks
BASE
BNTX
SECOND
US Dollar
<% (signals.list.current.rate).substr(0,7) %>
<% (signals.list.current.absolute).substr(0,9) %>
(<% signals.list.current.percentage|toFixed:2 %>%)
OPEN
<% (signals.list.current.openrate).substr(0,9) %>
HIGH
<% (signals.list.current.high).substr(0,9) %>
LOW
<% (signals.list.current.low).substr(0,9) %>
BNTX Signals
DON'T WANT TO MISS ANY SIGNAL? GO PREMIUM
ACCESS ALL FX, COMMODITIES & CRYPTO SIGNALS. GO PREMIUM
<% signal.status %>
<% signal.analyst %>
Long Term
Entry Price
Stop Loss
Take Profit
PREMIUM ONLY
<% signal.stopLoss %>
N/A
PREMIUM ONLY
<% signal.takeProfit %>
N/A
PREMIUM ONLY
<% signal.analyst %>
<% signal.comment %>
Description
<% signal.description %>
BNTX Signals & Technical Analysis
Last Updated: <% indicators.interval.updated|date:'MMM d, y h:mm:ss a' %>
Market Trend
Strong Sell
Sell
Neutral
Buy
Strong Buy
Loading Market Trend ...
Market Sentiment
BUY: <% indicators.sentiment.buy.length %>
SELL: <% indicators.sentiment.sell.length %>
NEUTRAL: <% indicators.sentiment.neutral.length %>
Strong Sell
Sell
Neutral
Buy
Strong Buy
Trend Indicators
NAME
VALUE
ACTION
Bollinger Bands
UPPER: <% indicators.data[indicators.interval.active].bbands.value.upper %>
MIDDLE: <% indicators.data[indicators.interval.active].bbands.value.middle %>
LOWER: <% indicators.data[indicators.interval.active].bbands.value.lower %>
Sell
Buy
Parabolic SAR
<% indicators.data[indicators.interval.active].sar.value %>
Sell
Buy
Standard Deviation
<% indicators.data[indicators.interval.active].stddev.value %>
High Volatility
Low Volatility
Oscillators
NAME
VALUE
ACTION
RSI(14)
<% indicators.data[indicators.interval.active].rsi.value %>
Sell
Buy
MACD(12,26)
<% indicators.data[indicators.interval.active].macd.value %>
Buy
Sell
Neutral
ATR
<% indicators.data[indicators.interval.active].atr.value %>
High Volatility
Low Volatility
STOCH(9,6)
<% indicators.data[indicators.interval.active].stochastics.value %>
Buy
Sell
ADX
<% indicators.data[indicators.interval.active].adx.value %>
High Volatility
Low Volatility
Moving Averages
PERIOD
SIMPLE
EXPONENTIAL
MA5
<% indicators.data[indicators.interval.active].sma5.value %>
Buy
Sell
<% indicators.data[indicators.interval.active].ema5.value %>
Buy
Sell
MA10
<% indicators.data[indicators.interval.active].sma10.value %>
Buy
Sell
<% indicators.data[indicators.interval.active].ema10.value %>
Buy
Sell
MA20
<% indicators.data[indicators.interval.active].sma20.value %>
Buy
Sell
<% indicators.data[indicators.interval.active].ema20.value %>
Buy
Sell
MA50
<% indicators.data[indicators.interval.active].sma50.value %>
Buy
Sell
<% indicators.data[indicators.interval.active].ema50.value %>
Buy
Sell
MA100
<% indicators.data[indicators.interval.active].sma100.value %>
Buy
Sell
<% indicators.data[indicators.interval.active].ema100.value %>
Buy
Sell
Pivot
PIVOT
CLASSIC
FIBONACCI
CAMARILLA
WOODIE
S3
<% indicators.data[indicators.interval.active].pp.data.result.classic.s3 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s3 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s3 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.s3 %>
S2
<% indicators.data[indicators.interval.active].pp.data.result.classic.s2 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s2 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s2 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.s2 %>
S1
<% indicators.data[indicators.interval.active].pp.data.result.classic.s1 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s1 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s1 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.s1 %>
PP
<% indicators.data[indicators.interval.active].pp.data.result.classic.pp %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.pp %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.pp %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.pp %>
R1
<% indicators.data[indicators.interval.active].pp.data.result.classic.r1 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r1 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r1 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.r1 %>
R2
<% indicators.data[indicators.interval.active].pp.data.result.classic.r2 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r2 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r2 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.r2 %>
R3
<% indicators.data[indicators.interval.active].pp.data.result.classic.r3 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r3 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r3 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.r3 %>
About (BNTX) BioNTech SE
Company Background
BioNTech SE, a German biotechnology company, is a pioneer in the development of personalized immunotherapies for the treatment of cancer and infectious diseases. Founded in 2008, BioNTech has rapidly advanced its innovative mRNA technology platform, which garnered international attention during the COVID-19 pandemic with the development of its highly effective vaccine in collaboration with Pfizer. Headquartered in Mainz, Germany, the company focuses on creating transformative therapies that harness the body’s immune system to fight diseases more effectively.Market Position
As a leader in the biotechnology sector, BioNTech is positioned at the forefront of the global race to develop targeted therapies and vaccines. The company’s pioneering work in mRNA technology has established it as a key player in the biotech industry. BioNTech’s diverse product pipeline includes therapies for various cancers and infectious diseases, with several candidates in late-stage clinical trials. The company's market capitalization and strong partnerships with pharmaceutical leaders underscore its significant role in advancing medical science and improving patient outcomes.Key Financial Highlights
BioNTech’s financial performance has witnessed remarkable growth due to the unprecedented demand for its COVID-19 vaccine. As of the most recent fiscal reports, the company has generated substantial revenues, allowing for increased investments in research and development. This financial strength enables BioNTech to explore new opportunities in biotechnology, including its promising pipeline of personalized cancer therapies and next-generation vaccines. Analysts anticipate continued growth, driven by ongoing innovation and strategic collaborations, positioning BioNTech favorably within the competitive landscape of biotechnology.Industry Highlights
The biotechnology industry is experiencing robust growth, propelled by advancements in genetic research and technology. BioNTech is at the cutting edge of this evolution, leveraging its mRNA expertise not only for vaccines but also for therapeutic applications. With a strong focus on personalized medicine and immunotherapy, BioNTech is well-equipped to meet the challenges of modern healthcare. The company's ongoing commitment to scientific excellence and collaborative partnerships positions it as a key contributor to the future of medicine, enhancing its long-term prospects as a prominent player in the biotechnology market.Related Stocks
Sidebar rates
Related Pairs
Multi Charts
- <% signal.pair %>
<% signals.active.Current.rate.substr(0,7) %>
<% signals.active.Current.absolute.substr(0,7) %> (<% signals.active.Current.percentage %>%)
